Jilin Aodong Yanbian Pharmaceutical Co., Ltd. announced a private placement of convertible bonds for gross proceeds of CNY 200,000,000 from returning investor Jilin Aodong Medicine Industry Group Co., Ltd on August 30, 2023. After the transaction, the company will own 727,717,286 shares representing a 99.99% of total issued share capital. The transaction has been approved at the 2nd session of the company?s 11th directorate and the 2nd session of the company?s 11th supervisory board.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.08 CNY | +2.65% | +2.17% | -0.40% |
Apr. 17 | Aodong Medicine's 2023 Profit Declines 18%; Revenue Up 20% | MT |
Apr. 16 | Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.40% | 2.49B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 000623 Stock
- News Jilin Aodong Pharmaceutical Group Co., Ltd.
- Jilin Aodong Yanbian Pharmaceutical Co., Ltd. announced that it expects to receive CNY 200 million in funding from Jilin Aodong Pharmaceutical Group Co., Ltd.